12/24
06:15 am
clls
Cellectis (NASDAQ:CLLS) was upgraded by analysts at Clear Str Llc to a "strong-buy" rating.
Low
Report
Cellectis (NASDAQ:CLLS) was upgraded by analysts at Clear Str Llc to a "strong-buy" rating.
12/15
05:35 pm
clls
Cellectis Announces Arbitral Decision in Dispute with Servier [Yahoo! Finance]
Medium
Report
Cellectis Announces Arbitral Decision in Dispute with Servier [Yahoo! Finance]
12/15
04:51 pm
clls
Cellectis Announces Arbitral Decision in Dispute with Servier
High
Report
Cellectis Announces Arbitral Decision in Dispute with Servier
12/8
01:30 am
clls
ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL
Low
Report
ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL
11/19
06:18 am
clls
Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells
Medium
Report
Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells
11/7
11:08 pm
clls
Cellectis GAAP EPS of $0.01 beats by $0.24, revenue of $37.16M [Seeking Alpha]
Medium
Report
Cellectis GAAP EPS of $0.01 beats by $0.24, revenue of $37.16M [Seeking Alpha]
11/7
04:49 pm
clls
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
11/7
04:30 pm
clls
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update
Medium
Report
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update
11/3
09:15 am
clls
Cellectis to Present a Development Update for eti-cel at ASH 2025
Medium
Report
Cellectis to Present a Development Update for eti-cel at ASH 2025
10/31
04:30 pm
clls
Cellectis to Report Third Quarter Financial Results on November 7, 2025
Medium
Report
Cellectis to Report Third Quarter Financial Results on November 7, 2025
10/20
07:21 am
clls
Cellectis (NASDAQ:CLLS) had its "positive" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
Cellectis (NASDAQ:CLLS) had its "positive" rating reaffirmed by analysts at Wells Fargo & Company.
10/17
06:03 am
clls
Cellectis (NASDAQ:CLLS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Medium
Report
Cellectis (NASDAQ:CLLS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
10/16
03:19 pm
clls
Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL
Medium
Report
Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL
10/16
07:00 am
clls
Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers
Medium
Report
Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers
10/7
02:53 am
clls
Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress [Yahoo! Finance]
Medium
Report
Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress [Yahoo! Finance]
10/7
02:40 am
clls
Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress
Medium
Report
Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress